Showing results (161-170 of 174) with videos related to
Sort By:
Pageof 18
The Lancet. Gastroenterology & Hepatology|December 9, 2023
Implementation of a liver health check in people with type 2 diabetesKushala W M Abeysekera, Luca Valenti, Zobair Younossi, et al.Gut|February 5, 2021
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?Ramy Younes, Olivier Govaere, Salvatore Petta, et al.Scientific Reports|February 7, 2019
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanismsRasha El Sharkawy, Ali Bayoumi, Mayada Metwally, et al.Journal of Viral Hepatitis|June 3, 2022
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patientsGamal Shiha, Reham Soliman, Nabiel N H Mikhail, et al.Gut|January 10, 2024
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver diseaseAngelo Armandi, Tiziana Sanavia, Ramy Younes, et al.Journal of Hepatology|April 12, 2020
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementMohammed Eslam, Philip N Newsome, Shiv K Sarin, et al.Gastroenterology|May 8, 2020
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and NoncarriersCarolin V Schneider, Karim Hamesch, Annika Gross, et al.Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.Hepatology International|May 19, 2023
An international multidisciplinary consensus statement on MAFLD and the risk of CVDXiao-Dong Zhou, Giovanni Targher, Christopher D Byrne, et al.Annals of Hepatology|January 11, 2026
The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver diseaseYasser Fouad, Reda Elwakil, Faisal M Sanai, et al.Pageof 18